Melanoma Flashcards

1
Q

What type of growth phase do most melanomas begin with?

A
  • horizontal growth phase
  • this is where melanocytes form nests along the basal layer
  • later they will migrate and form nests in the upper layers of the epidermis
  • this growth can last 15 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the second growth phase of melanomas called?

A
  • vertical growth phase
  • melanocytes descend across the basal lamina and into the dermis
  • during this phase nodules can become raised on the skin’s surface
  • can invade blood and lymphatics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Epidemiology

A
  • 15 to 19 years, M:F equal
  • 30 to 40 years, M:F 1:2
  • 1 in 56 women and 1 in 37 men
  • men predominantly on the trunk
  • women mainly on the lower extremities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Risk for melanoma increases when?

A
  • increased sun exposure (UVB)
  • fair-skinned
  • red haired, blue eyed (triple incidence)
  • increased age (peak at 40 years)
  • patients with melanoma have a 5% risk of developing a second melanoma
  • patients with dysplastic nevus syndrome
  • 8 times the risk if theres a family history
  • linked to intense and intermittent sun exposure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ABCDEs of melanoma

A

Review this slide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the melanoma subtypes and their prevalences

A
  1. Superficial spreading (70%)
  2. Nodular (15-20%)
  3. Lentigo maligna (10-15%)
  4. Acral lentiginous (<5%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Superficial spreading

A

AKA radical spreading melanomas

  • intermittent sun exposure
  • trunk and extremities
  • occurs in 40-50 years of age
  • slow evolution of change in a mole, followed by a period of rapid growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Nodular

A
  • appear at middle age (50s-60s)
  • early vertical growth, raised, protrudes, bleeds easily
  • can arise without pre-existing nevus
  • face, chest, back
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lentigo maligna

A

AKA Hutchunson’s Freckles

  • large, flat, tan with irregular border
  • gets darker as it grows
  • face, ears, arms
  • chronic sun exposure
  • 60s-70s
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Acral lentiginous

A
  • 35 to 60% asians, hispanics, African descent
  • palms, soles, subungual areas
  • average age is 60 years
  • not linked to sun exposure
  • dark brown or black flat spot
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diagnosis

A
  • physical exam and history
  • dermoscopy
  • excisional biopsy
  • FNA or SLNB and PET
  • baseline CXR (lung mets)
  • lab work (melanin in urine, blood including LDH for mets to liver)
  • CT (chest, abdo, pelvis) thickness>4mm
  • MR (mets to brain or spinal cord)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Routes of spread

A
  1. local-via satellite nodules, subcutaneous tissue
  2. lymphatic-local regional lymph nodes
  3. Hematogenous-liver, lung, bone, brain
  4. Rare-GI tract, adrenal gland
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Micro staging systems

A

Review lecture notes

Clark’s-depth of invasion
Breslow’s-bulk of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

TNM staging

A

Early stage: stages 0-2c
Locoregional: stage 3
Metastatic: stage 4

Review TNM staging notes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the primary treatment

A

Surgery

Small lesions (0-1.5 mm): 1 cm margin
Intermediate lesions (>1.5-4 mm): 1-2 cm margin
Larger lesions (>4 cm): 3 cm margin laterally and into fascia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What needs to be done to lymph nodes

A

Early stage-SLNB
Complete nodal dissection when lesions are between 1-4 mm because about 20% of patients are expected to have nodal mets (T2-T4)

17
Q

Adjuvant treatments?

A

Typically, because recurrence is high

-RT, chemo or immunotherapy

18
Q

immunotherapy

A
  • 16% of metastatic melanomas may respond to immunological approaches
  • BRAF inhibitors
  • Interleukin-2: 25% response rates, high costs and toxicity
  • Interferon: delays recurrence but toxic
19
Q

When is RT used

A
  1. May be useful as a primary or adjuvant modality when patients refuse surgery or are debilitated
  2. Multiple large lymph nodes
  3. Extracapsular spread
  4. Local recurrence in a previously dissected lymph node basin
  5. Metastatic disease
  6. Recurrent disease
  7. Stages 3c or 4
20
Q

RT prescription

A

55 Gy/ 30 fractions=moderate to large inner canthus, eyelid, nasal or pinna lesions

45 Gy/ 15 fractions=moderate-sized lesions on free skin or postoperative treatment to moderate-sized cancer on “free” skin with positive margins

40 Gy/ 10 fractions, 30 Gy/ 5 fractions, 20 Gy/ 1 fraction=high cure rate for small lesions but cosmetic results less than optimal after 5 years

21
Q

RT for palliative cases

A

POP (6 or 15 MV)
2000 cGy/ 5 fractions
3000 cGy/ 10 fractions

SBRT: bone mets

SRS solitary mets (brain)
-16-25 Gy to 80% isodose

22
Q

Acute and chronic side effects of RT

A

Acute:

  1. erythema
  2. dry/moist desquamation
  3. epilation

Chronic:

  1. decreased or absence of sebaceous and sudoriferous gland function
  2. fibrosis
  3. hypersensitivity
  4. telangiectasia